Omada Health has officially launched the roadshow for its initial public offering, setting the stage to go public on the Nasdaq Global Market under the ticker symbol “OMDA.” The virtual-first healthcare company plans to offer 7.9 million shares of common stock at a price range of $18.00 to $20.00 per share, with an additional 1.185 million shares available to underwriters through a 30-day option. Leading the underwriting are Morgan Stanley, Goldman Sachs, and J.P. Morgan, with additional support from Barclays, Evercore ISI, Canaccord Genuity, and Needham & Company. The IPO follows Omada’s May 29 filing with the SEC, which is still pending effectiveness.
Founded on the premise of providing care between visits, Omada delivers digital programs targeting chronic conditions such as diabetes, hypertension, and musculoskeletal pain. Its approach centers on behavior change supported by clinical data and a dedicated care team model. With over 2,000 customers—including health systems and Fortune 500 employers—and nearly 30 peer-reviewed studies validating its outcomes, Omada positions itself as a data-driven solution to rising healthcare costs. The IPO marks a significant milestone for the company as it looks to scale its reach and influence in a competitive virtual care market.
